The Food and Drug Administration recently approved two novel thrombopoiesis-stimulating agents, Romiplostim (AMG-531, Nplate) and Eltrombopag (Promacta), for the treatment of adults with immune ...

65.4% of hospitalized ITP inpatients did not have a bleeding episode or surgical procedure associated with their platelet transfusion. Platelet transfusions were not associated with improved clinical ...

What is the role of platelet transfusion in patients who require massive blood transfusions? The authors reviewed transfusion records and mortality data from patients who required ≥ 10 packed red ...

February 18, 2010 — Low doses of platelets given prophylactically led to a decreased number of platelets transfused per patient but an increased number of transfusions given, according to the results ...

A group of 12 thrombocytopenic patients, ranging in age from two to fourteen years, were studied. The thrombocytopenia was due to diverse conditions (Table 1). The platelet count ranged from 3000 to ...

THE variability in the natural history of both acquired and idiopathic aplastic anemia makes it difficult to evaluate the success of any specific program of therapy. With careful attention to ...

There is an increasing demand for single donor platelet transfusions due to intensive chemotherapy and blood stem cell or bone marrow transplantation. Platelet transfusions however are expensive and ...

The use of low-dose platelet transfusion in patients undergoing hematopoietic stem-cell transplantation with platelet counts less than 10,000/mm 3 did not significantly affect bleeding compared with ...

Please provide your email address to receive an email when new articles are posted on . ATLANTA — More patients with hematologic malignancies who followed a no-prophylaxis platelet transfusion policy ...

People hospitalized with certain rare blood cell disorders frequently receive a treatment that is associated with a two- to fivefold increase in death, according to a new study that reviewed hospital ...

People hospitalized with certain rare blood cell disorders frequently receive a treatment that is associated with a two- to fivefold increase in death, according to a new study that reviewed hospital ...